维普期刊资源整合服务平台（V6.5）

58篇 您的检索式：作者名="Cambau"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy显示文摘Post-exposure prophylaxis(PEP)for leprosy is administered as one single dose of rifampicin(SDR)to the contacts of newly diagnosed leprosy patients.SDR reduces the risk of developing leprosy among contacts by around 60%in the first 2–3 years after receiving SDR.In countries where SDR is currently being implemented under routine programme conditions in defined areas,questions were raised by health authorities and professional bodies about the possible risk of inducing rifampicin resistance among the M.tuberculosis strains circulating in these areas.This issue has not been addressed in scientific literature to date.To produce an authoritative consensus statement about the risk that SDR would induce rifampicin-resistant tuberculosis,a meeting was convened with tuberculosis(TB)and leprosy experts.The experts carefully reviewed and discussed the available evidence regarding the mechanisms and risk factors for the development of(multi)drug-resistance in M.tuberculosis with a view to the special situation of the use of SDR as PEP for leprosy.They concluded that SDR given to contacts of leprosy patients,in the absence of symptoms of active TB,poses a negligible risk of generating resistance in M.tuberculosis in individuals and at the population level.Thus,the benefits of SDR prophylaxis in reducing the risk of developing leprosy in contacts of new leprosy patients far outweigh the risks of generating drug resistance in M.tuberculosis.	Liesbeth Mieras Richard Anthony Wim van Brakel Martin W.Bratschi Jacques van den Broek Emmanuelle Cambau Arielle Cavaliero Christa Kasang Geethal Perera Lee Reichman Jan Hendrik Richardus Paul Saunderson Peter Steinmann Wing Wai Yew	2016	Infectious Diseases of Poverty2016，5，1：	2
2	Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid显示文摘	Cambau E Bordon F Collatz E	1993	Antimicrobial Agents and Chemotherapy1993，37，：	1
3	Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis:functional analysis of mutant enzymes显示文摘	Aubry A Veziris N Cambau E	2006	Antimicrob Agents Chemother2006，50，1：	1
4	Novel gyrase mutations in quinolone-resistant and hypersusceptible clinical isolates of Mycobacterium tuberculosis:functional analysis of mutant enzymes显示文摘	Aubry A Veziris N Cambau E	2006	Antimicrob Agents Chemother2006，50，1：	1
5	Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005 显示文摘	Cambau E Lascols C Sougakoff W	2006	Clin Microbiol Infect2006，12，10：	1
6	Sequences of Conserved Region in the A Subunit of DNA Gyrase from Nine Speeies of the genus Mycobaeterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolones 显示文摘	Guillemin I Cambau E Jarlier V	1995	Antimierob Agents Chemother1995，39，9：	1
7	Evaluation of the new MB redox system for detection of growth of mycobacteria显示文摘	Cambau E Wichlacz C Truffot-Pernot C	1999	J Clin Microbiol1999，37，：	1
8	Real-time PCR for fast detection of plasmid-mediated qnr genes in extended spectrum beta-lactamase producing Enterobacteriaceae显示文摘	Guillard T Cavallo J D Cambau E		0，，：	1
9	Real-time PCR forfast detection of plasmid-mediated qnr genes in extended spec-trum beta-lactamase producing Enterobacteriaceae 显示文摘	Guillard T Cavallo JD Cambau E	2010	PatholBiol(Paris)2010，58，6：	1
10	Evaluation of the new MB redox system for detection of growth of mycobac teria显示文摘	Cambau E Wichlacz C Truffot-Pemot C	1999	J Clin Microbiol1999，37，6：	1
11	Novel gyrase mutationsin quinolone-resistant and -hypersusceptible clinical isolates ofMycobacterium tuberculosis : functional analysis of mutant en-zymes显示文摘	Aubry A Veziris N Cambau E	2006	Antimicrob Agents Chemother2006，50，1：	1
12	Mechanisms of resistance to quinolone 显示文摘	Cambau E Gutmann L	1999	Drugs1999，45，13：	1
13	Myeobaeterial growth indicator tube versus the proportion method on Lowen- stein-Jensen medium for antibiotic susceptibility testing of Myco- hacterium tuberculosis显示文摘	Cambau E Truffot-pernot C Boulahbal F	2000	Eur J ClinMicrobiol Infect Dis2000，19，12：	1
14	Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli显示文摘	CAMBAU E MATRAT S PAN XS et ol	2009	J Antimicrob Chemother2009，63，3：	1
15	Expression and purification of an active form of the Myeobacterium leprae DNA gyrase and its inhibition by quinolones 显示文摘	Matrat S Petrella S Cambau E	2007	Antimicrob Agents Chemother2007，51，：	1
16	Absence of mycobacterium tubercu- losis in arterial lesions from patients with Takayasu' s arteritis 显示文摘	Arnaud L Cambau E Brocberiou I	2009	J Rheuma- to12009，36，：	1
17	Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005显示文摘	Cambau E Lascols C Sougakoff W	2006	Clin Microbiol Infect2006，12，10：	1
18	A diaryl quinoline drug active on the ATP synthase of My cobacterium tuberculosis显示文摘	Andries K Verhasselt P Guillemont J Gohlmann H W H Neefs J M Winkler H VanGestel J Timmerman P Zhu M Lee E Williams P de Chaffoy D Huitric E Hoffner S Cambau E Truffot-Pernot C Lounis N Jarlier V	2005	Science2005，307，：	1
19	Role of mutation in DNA gyrase genes in susceptible or resistant to imipenem显示文摘	Cambau Eperani E	1995	Antimicrob Agents chemother1995，39，10：	1
20	Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA Gyrase in Mycobacterium显示文摘	Guillemin I Jarlier V Cambau E	1998	Anitimicrobial agents and chemotherapy1998，42，8：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示